OpenAI has acquired the startup Orchestra Bio, the company says, in a move to expand its work in biotechnology. According to OpenAI, Orchestra’s team and technology will support Rosalind, its AI model focused on life sciences research, and the related Rosalind Workbench tool. The Workbench is described as a harness intended to help researchers plan experiments and analyze their results.
Why it matters
The acquisition signals OpenAI’s continued investment in applying AI models to life sciences, bringing additional personnel and technology to its existing Rosalind efforts.
Who should care
Researchers working in life sciences and organizations following OpenAI’s expansion into biotech-focused AI tools.